Target intelligence / Profile preview

Tumor suppressor candidate 1 (TUSC1)

Target
TUSC1
Molecular classification
Other
01

Overview

Tumor suppressor candidate 1 (TUSC1) is a protein encoded by an intronless gene located on chromosome 9p21.2, identified as a putative tumor suppressor[1][2][3]. TUSC1 expression is often reduced or lost in cancer cells, including lung cancer and hepatocellular carcinoma, where downregulation is associated with tumor progression and adverse prognosis[1][2][3]. Restoration of TUSC1 expression in tumor cell lines suppresses cell proliferation in vitro and inhibits tumor growth in vivo, indicating its tumor suppressive capacity[1]. Loss of TUSC1 expression can result from mechanisms such as intragenic hypermethylation, making epigenetic status of the TUSC1 gene a promising prognostic biomarker in certain malignancies[2][3]. TUSC1 localizes to both the cytoplasm and nucleus, but its detailed biological pathways and interacting partners remain to be fully elucidated. Currently, no drugs are known to directly target TUSC1, nor is there evidence it serves as a direct therapeutic target (such as a receptor or enzyme).

Other names
Tumor suppressor candidate gene 1 proteinTSG9TSG-9CCDC89B
02

Biological functions

Tumor suppressionRegulation of cell proliferationRegulation of cell growth
03

Disease associations

Cancer (including lung cancer, hepatocellular carcinoma)
04

Biomarkers

Prognostic biomarker (e.g., high TUSC1 expression correlates with better survival in lung cancer; intragenic hypermethylation is a negative prognostic marker in hepatocellular carcinoma)

Beyond the preview

Go deeper on Tumor suppressor candidate 1 (TUSC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor suppressor candidate 1 (TUSC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call